gms
Accesskeys
- [Alt + 0] - Homepage
- [Alt + 1] - to the top
- [Alt + 5] - Search Form
- [Alt + 6] - Sitemap
- [Alt + 7] - to within-page navigation
- [Alt + 8] - to content
- [Alt + 9] - Contact Form
Global Servicelinks
Navigation
content
Detailed Information: gms (GA03)
The gms (German Medical Science) database contains bibliographic data of medical research articles, linked with the corresponding full texts. These original full texts are available as html-files or as PDF. All the articles published in gms are available online for anyone interested: immediately, permanently and free of charge.
The Association of the Scientific Medical Societies in Germany (AWMF) and their scientific associations supply the Editorial Board, the Scientific Committee as well as the experts for the Peer-Review-Procedure. The editiorial work and the workflow is in the hands of the German National Library of Medicine (ZB MED). The German Institute of Medical Documentation and Information (DIMDI) is responsible for the technical implementation and the longterm archiving of electronic documents.
Content navigation
- Database Content: Subject Coverage | Type | Language | Sources | Superbases
- Database Resources: File Size | File Data | Update Cycle
- Query: User Aids | Special Notes | Vocabulary | Searchable Data Fields | Data Fields, alphabetical | Output of Search Results | Sample Search(es) | Sample Record(s)
- Contact: Producer | Contact Person
- Appendix: Appendix
Database Content
| Subject Coverage | Health Policy, medicine and related fields |
|---|---|
| Type | Full text database |
| Language | German, English |
| Sources | German Medical Science e-journal and portal free of charges: http://www.egms.de/en/index.htm |
| Superbases | There are predefined databases groups (superbase) for several subjects. The database gms is part of the following superbases: |
Database Resources
| File Size | 2,808 (Status 06/2012) |
|---|---|
| File Data |
You will find the number of database records in the current update status. |
| Update Cycle | Daily |
Query
User Aids
Special Notes
Original papers and reviews that have passed through a peer review are published therein.
The Association of the Scientific Medical Societies in Germany (AWMF) and their scientific associations supply the Editorial Board, the Scientific Committee as well as the experts for the Peer-Review-Procedure. The editiorial work and the workflow is in the hands of the German National Library of Medicine (ZB MED). The German Institute of Medical Documentation and Information (DIMDI) is responsible for the technical implementation and the long-term archiving of electronic documents.
Standing orders (SDI) are possible for Premium customers.
Vocabulary
Controlled Terms (CT)
Controlled Terms German (CTG)
Uncontrolled Terms (UT)
Uncontrolled Terms German (UTG)
Subject Heading (SH)
Chemical Terminology (TE)
The vocabulary language is English
Searchable Data Fields
The following document sections are considered with the free text search (FT):
Abstract (AB)
Device Name (CDEV)
Controlled Terms (CT)
Controlled Terms German (CTG)
Device Manufacturer Name (DMN)
Drug Name (DN)
Document Type (DT)
Drug Manufacturer Name (MN)
Notes (NOTE)
Subject Heading (SH)
Chemical Terminology (TE)
Title (TI)
Uncontrolled Terms (UT)
Uncontrolled Terms German (UTG)
Search language(s) in the basic index:
German and English.
Data Fields, alphabetical
Explanation:
D = DISPLAY F = FIND S = SHOW
1: front-end-masking recommended
2: searchable word by word with field label
(F): field is searchable only via basic index
| Command | Field Name | Examples | Notes |
|---|---|---|---|
| (F) S | AB Abstract | F behandlung?/AB F treatment?/AB |
Divided in ABE (Abstract Englisch) and ABG (Abstract German). 75% Abstracts. |
| D F S | AL Abstract Language | F AL=english D AL=? |
Specifies the abstract language. |
| D F S | AU Author | F AU=pfeiffer m F AU=pfeiffer ? |
End-masking required, if first name is not known. |
| S | AUF Author Function | AU:: Grulke N (corrsponding author) | Shown in field AU. Terms used are author, corresponding author and editor. |
| D 2 F 2 S | CA Corporate Author | F CA=hta expert | |
| D F S | CDEV Common Device Name | F CDEV=orange filter? | Masking recommended. |
| D 2 F 2 S | CF Conference | Still without content. | |
| D 2 F 2 S | CORR Correction | Information about corrections, e.g. order of authors | |
| D F S | CS Corporate Source | F CS=universit? | |
| D F S | CT Controlled Terms- | F CT=adult D CT=? |
Equivalent to CTE |
| /QF=xx | F vertebrae/QF=surgery | To qualify controlled terms. | |
| D F S | CTE Controlled Terms English | F CTE=adult D CTE=? |
Only English terms are searchable. |
| D F S | CTG Controlled Terms German | F CTG= erwachsener D CTG=? |
Only German terms are searchable. |
| D F S | DA Date Accepted | F DA=20030630 | Date of acceptance of a manuscript |
| D F S | DLCORR Date Last Correction | Date of the last correction | |
| D F S | DLERR Date Last Erratum | F DLERR=20070724 | Part of SHOW F=ERRATUM |
| D F S | DMN Device Manufacturer Name | F DMN=amgen F amgen/DMN |
|
| D F S | DN Drug Name | F DN=neupogen F neupogen/DN |
|
| D F S | DOI Digital Object Identifier | D DOI=? F DOI= "10.3205/hta000066" |
Must be set in quotation marks. A DOI is a unique and persistent identification code for digital objects. Since November 2008 used in gms. |
| D F S | DR Date Received | F DR=2003? D DR=? |
Date article was received in the editorial system. |
| D F S | DREV Date Revised | Still without content. | |
| D F S | DT Document Type | F ... AND DT=research article D DT=? |
Combination of search term and DT is recommended. |
| D F S | EDR Editor | Still without content. | |
| D 2 F 2 S | ERR Erratum | D ERR=? | Cause of Erratum. Part of SHOW F=ERRATUM |
| D F S | ISSN International Standard Serial Number | F ISSN=1612-3174 | |
| D 1 F 1 S | JT Journal Title | F JT=german medical science F JT=gms german medical science |
Since 2005 all journal titles begin with "gms" for german medical science. Therefore it is necessary to search e.g. F JT=?german medical science to find all documents of that journal |
| D F S | LA Language | F LA=english | Language of the original article. |
| D F S | MN Drug Manufacturer Name | F MN=amgen F amgen/MN |
|
| D F S | ND Document Number | F ND=GA000007 | Unique Number of Document. |
| (F) S | NOTE Notes | Still without content. | |
| D 1 F 1 S | PD Publication Date | F PD=20031103 | Part of SO. |
| D 2 F 2 S | PU Publisher | F PU=german medical science | |
| D F S | PY Publication Year | F ... AND PY=2003 | Combination of search term and PY is recommended. |
| D F S | QF Qualifier | F QF=surgery D QF=? |
see List of Qualifiers |
| D F S | RF References | F RF=buti m? | Contains referenced author, title, journal and publication data. |
| F RF=buti m?/RY=2000 | Qualification by the cited year (RY) is possible. | ||
| D F S | RPU Date Republished | F RPU=20070724 | |
| D F S | SC Subject Heading Code | F SC=610 | Special group division of the German National Library. |
| D 2 F 2 S | SE Serials Title | Still without content. | |
| D F S | SH Subject Headings | F SH=immunologie | Subject Headings not corresponding with Subject Code |
| S | SO Source | SO: German Medical Science; VOL: 1; DOC07 /20031103/ | Contains journal title, volume, online document number, publication date, link to the full-text. |
| D F S | TE Chemical Terminology | F TE=bleomycin | |
| (F) S | TI Title | F problem/TI | Contains original and translated title. |
| D F S | URN Uniform Resource Name | D URN=? URN: urn:nbn:de:0183-hta0000660 |
A URN is a unique and persistent identification code. Since November 2008 used in gms. |
| D F S | UT Uncontrolled Terms | F UT=anatomy F anatomy/UT |
|
| D F S | UTG Uncontrolled Terms German | F UTG=anatomie F anatomie/UTG |
Output of Search Results
By means of the commands SHOW (S) / MAIL / SDI.
Corresponding to the copyright rules use the parameter USE=DLOAD, if necessary. You may ask for all data fields, single data fields, or sets of data fields. If the output fields are not specified explicitly, the standard field set (F=STD) is used in all output commands.
Output field sets:
| Command | Field Set | Associated Datafields |
|---|---|---|
| F=STD | standard | Same as F=ALL without RF |
| F=ALL | all fields | ND, AU(F), CA, TI, CF, CS, EDR, SO, DOI, URN, DLERR, ERR, DLCORR, CORR, PU, SE, LA, ISSN, ISS, DT, SC, CT, CTG, UT, UTG, TE, SH, DR, DA, DREV, RPU, PY, DN, CDEV, DMN, MN, NOTE, AB, RF |
| F=BIB | bibliographic fields | ND, AU(F), CA, TI, CF, SO, DOI, URN, DLERR, ERR, DLCORR, CORR, PU, SE, LA, ISSN, DT |
| F=DES | descriptors | CT, CTG, CDEV, DN, DMN, MN, SC, UT, UTG, TE, SH, |
| F=ERRATUM | Erratum | DLERR, ERR |
Sample Search(es)
Database selection in DIMDI ClassicSearch: SBAS GA03
Subject: Search for articles about vaccination against Human papillomavirus (HPV) .
Profile table:
| Parameter | Counter | Number of Hits | Query |
|---|---|---|---|
| C= | 1 | 2038 | GA03 |
| S= | 2 | 1 | F (vaccination AND (Human papillomavirus OR HPV))/TI |
Sample Record(s)
2/1 of 1 DIMDI: German Medical Science (GA03) © gms
| ND: | GAhta000066 |
| AU(F): | Damm O (author); Nocon M (author); Roll S (author); Vauth C (corresponding author); Willich S (author); Greiner W (author) |
| CS: | Forschungsstelle für Gesundheitsökonomie und Gesundheitssystemforschung, Gottfried Wilhelm Leibniz Universität Hannover, Königsworther Platz 1, 30167 Hannover, Tel.: 0511/7625084 |
| TI: | Impfung gegen humane Papillomaviren (HPV) zur Prävention HPV 16/18 induzierter Zervixkarzinome und derer Vorstufen Human papillomavirus HPV vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors |
| SO: | GMS Health Technology Assessment; VOL: 5; DOC04 /20090311/ |
| http://www. egms.de/en/ gms/2003-1/000007.shtml | |
| http://www. egms.de/pdf/ gms/2003-1/000007.pdf | |
| http://www. egms.de/xml/ gms/2003-1/000007.xml | |
| DOI: | 10.3205/hta000066 |
| URN: | urn:nbn:de:0183-hta0000660 |
| PU: | German Medical Science GMS Publishing House; Düsseldorf |
| LA: | German |
| ISSN: | 1861-8863 |
| DT: | HTA-Kurzfassung |
| SC: | 610 |
| CT: | CERVICAL INTRAEPITHELIAL NEOPLASIA; UTERINE CERVICAL NEOPLASMS; CANCER VACCINES; HPV VACCINES; PAPILLOMAVIRUS VACCINES; COSTS AND COST ANALYSIS |
| CTG: | ZERVIKALE INTRAEPITHELIALE NEOPLASIE; ZERVIXTUMOREN; KREBSVAKZINE; PAPILLOMAVIRUS-VAKZINE; PAPILLOMAVIRUS-VAKZINE; KOSTEN UND KOSTENANALYSE |
| PY: | 2009 |
| ABE: | Introduction Essential precondition for the development of cervical cancer is a persistent human papillomavirus (HPV) infection. The majority - approximately 70% - of cervical carcinomas is caused by two high-risk HPV types (16 and 18). Recently, two vaccines have been approved to the German market with the potential to induce protection against HPV 16 and HPV 18 among additional low-risk virus types. Objectives To analyse whether HPV vaccination is effective with regard to the reduction of cervical cancer and precursors of cervical carcinoma (CIN), respectively? Does HPV vaccination represent a cost-effective alternative or supplement to present screening practice? Are there any differences concerning cost-effectiveness between the two available vaccines? Should HPV vaccination be recommended from a health economic point of view? If so, which recommendations can be conveyed with respect to a (re)organization of the German vaccination strategy? Which ethical, social and legal implications have to be considered? ... (abbreviated) |
| ABG: | Einleitung Notwendige Voraussetzung für die Entstehung von Zervixkarzinomen ist eine persistierende Infektion mit humanen Papillomaviren (HPV). Die HPV-Typen 16 und 18 verursachen mit etwa 70% den überwiegenden Teil der Zervixkarzinome. Seit 2006/2007 stehen zwei Impfstoffe gegen HPV 16 und 18 zur Verfügung. Fragestellung Wie effektiv ist die HPV-Impfung hinsichtlich der Reduktion von Zervixkarzinomen bzw. ihren Vorstufen (CIN)? Stellt die HPV-Impfung eine kosteneffektive Ergänzung zur derzeitigen Screeningpraxis dar? Gibt es Unterschiede bezüglich der Kosten-Effektivität zwischen den beiden verfügbaren Impfstoffen? Sollte aus gesundheitsökonomischer Perspektive eine Empfehlung für den Einsatz der HPV-Impfung gegeben werden? Falls ja, welche Empfehlungen bezüglich der Ausgestaltung einer Impfstrategie lassen sich ableiten? Welche ethischen, sozialen und juristischen Implikationen sind zu berücksichtigen?... (abbreviated) |
Output format: SHOW F=STD
Contact
Producer
- GMS German Medical Science gGmbH
Ubierstraße 20
40223 Düsseldorf
Germany
Phone: +49 211 31 28 28
Fax: +49 211 31 68 19
Contact Person
- Database Search:
DIMDI
Phone: +49 221 4724-315
E-mail: Helpdesk Databases - Service, Contract, Prices:
DIMDI
Phone: +49 221 4724-270
E-mail: Technical Helpdesk
Appendix
Appendix
1. List of Preprocessed Searches
AIDS
CANCER
HUMAN
2. List of Qualifiers
Abnormalities
Administration & Dosage
Adverse effects
Analysis
Biosynthesis
Blood
Cerebrospinal Fluid
Chemically induced
Chemistry
Classification
Complications
Congenital
Cytology
Diagnosis
Diet Therapy
Drug Effects
Drug Therapy
Economics
Education
Epidemiology
Etiology
Genetics
Immunology
Instrumentation
Metabolism
Methods
Microbiology
Mortality
Organization & Administration
Pathology
Pharmacokinetics
Pharmacology
Physiology
Physiopathology
Prevention & Control
Psychology
Radiation Effects
Radiography
Radionuclide imaging
Radiotherapy
Rehabilitation
Standards
Statistics & Numerical Data
Surgery
Therapeutic Use
Therapy
Ultrasonography
Utilization
Virology
- Copyright: DIMDI -